Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Med Dosw Mikrobiol ; 41(2): 100-5, 1989.
Article in Polish | MEDLINE | ID: mdl-2586189

ABSTRACT

The aim of this study was to evaluate a degree of contribution of mechanically cleansed municipal sewage in a spread in on environment of bacteria of Enterobacteriaceae family with special regard to antibiotic resistant strains. High number of bacteria of Enterobacteriaceae family was found in 1 ml of sewage and the number of antibiotic-resistant bacteria was 0.5-50 X 10(3)/ml. Among the strains tested the resistance to more than one antibiotics was encountered. 78.3% of strains transferred antibiotic resistance to E. coli recipient strain, what indicate a participation of potentially pathogenic bacteria from Enterobacteriaceae family in a spread of antibiotic resistance in a environment.


Subject(s)
Anti-Bacterial Agents/pharmacology , Disinfection/standards , Enterobacteriaceae Infections/etiology , Enterobacteriaceae/drug effects , Sewage , Waste Disposal, Fluid , Water Microbiology , Drug Resistance, Microbial , Humans , Poland , Sterilization , Urban Health/standards
2.
Zentralbl Bakteriol A ; 247(3): 347-52, 1980 Aug.
Article in English | MEDLINE | ID: mdl-6999802

ABSTRACT

Rabbits were infected with freshly isolated strains of Ps. aeruginosa, P. mirabilis, E. coli or K. pneumoniae and treated with gentamicin, amikacin or sisomicin in a controlled study. Therapeutic results were evaluated by survival of animals and viable counts of etiologic bacteria in several tissues after sacrification of treated animals at the same time. Sisomicin was the drug of choice for Ps. aeruginosa and P. mirabilis infections, when compared with amikacin and gentamicin. Its action is practically equal to that of amikacin in K. pneumoniae infection. Sisomicin appeared less active in E. coli infections than amikacin, but was superior to gentamicin.


Subject(s)
Amikacin/therapeutic use , Enterobacteriaceae Infections/drug therapy , Gentamicins/therapeutic use , Kanamycin/analogs & derivatives , Pseudomonas Infections/drug therapy , Sisomicin/therapeutic use , Animals , Escherichia coli Infections/drug therapy , Klebsiella Infections/drug therapy , Klebsiella pneumoniae , Proteus Infections/drug therapy , Proteus mirabilis , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL
...